Micron Technologies Announces Acquisition by Arlington Capital

An Approach to Particle Size Stability

Peter Nelson, Director of Analytical Services

Understanding particle size stability and monitoring particle size changes may be vital to product success

iconAn Approach to Particle Size Stability

 

Peter Nelson, Director of Analytical Services

Developing a Robust and Repeatable Particle Size Analysis Method -- Part 1

Peter Nelson, Director of Analytical ServicesDeveloping a Robust and Repeatable Particle Size Analysis Method -- Part 1

icon Developing a Robust and Repeatable Particle Size Analysis Method -- Part 1

 

 

Peter Nelson, Director of Analytical Services

Micronisation of Pharmaceutical Powders for Use in Inhalation

Jean Martin Larran, General Manager Micron Technologies Ltd.Due to the nature of the respiratory tract, depending on the indication for which the product is being developed, particle size of pharmaceutical powders for use in inhalation is critical. It will dictate which areas of the respiratory tract are targeted in order for the product to have the greatest efficacy. This article will cover different micronisation techniques used by the industry to achieve desired particle size, and will describe analytical techniques to test these particles and characterize the powders.

icon Micronisation of Pharmaceutical Powders for Use in Inhalation

Jean Martin Larran,

General Manager Micron Technologies Ltd.

Micron Technologies, Inc.

333 Phoenixville Pike
Malvern, Pa 19355
US +1 610-251-7400

Directions

Micron Technologies Ltd.

Crossways Blvd.
Crossways
Dartford
Kent DA2 6QY UK
UK +44 (0)1322 425200

Directions